A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung

Seminars in Oncology

Volumn 25, Issue 1 SUPPL. 2, 1998, Pages 8-14

  Masters, G A ^a   Hoffman, P C ^a   Drinkard, L C ^a   Samuels, B L ^a   Golomb, H M ^a   Vokes, E E ^a  

^a EVANSTON HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; NAVELBINE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DRUG EFFICACY; FEMALE; FEVER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MALE; MAXIMUM ALLOWABLE CONCENTRATION; MUCOSA INFLAMMATION; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IFOSFAMIDE; LUNG NEOPLASMS; VINBLASTINE;

EID: 0031956804     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)